Ki-67 expression in luminal type breast cancer and its association with the clinicopathology of the cancer

por YUAN, PENG, XU, BENLING, WANG, CHENGZHENG, ZHANG, CHENGJUAN, SUN, MIAOMIAO, YUAN, LONG
Publicado 2016

Exploration of prognostic factors and the value of adjuvant chemotherapy in T1a,bN0M0 triple-negative breast cancer: a prospective cohort study based on the SEER database

por Wu, Junzhao, Lv, Minhao, Yuan, Peng, Ma, Youzhao, Tian, Peiqi, Li, Lianfang, Wang, Chengzheng, Lu, Zhenduo, Yan, Min, Chen, Xiuchun, Liu, Zhenzhen
Publicado 2022

Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial

por Wang, Chengzheng, Liu, Zhenzhen, Chen, Xiuchun, Qiao, Jianghua, Lu, Zhenduo, Li, Lianfang, Sun, Xianfu, Zhang, Chongjian, Yue, Xiayu, Xia, Qingxin, Zhang, He, Yan, Min
Publicado 2023

Effect of the HER-2/CEP17 ratio in IHC 2+/FISH-amplified breast cancer on pathological complete response to neoadjuvant pertuzumab and trastuzumab treatment—a retrospective cohort...

por Wang, Jiabin, Qiao, Jianghua, Ruan, Yuxia, Wang, Chengzheng, Li, Lianfang, Lu, Zhenduo, Sun, Xianfu, Zhang, Chongjian, Chen, Xiuchun, Yan, Min, Cui, Shude, Liu, Zhenzhen
Publicado 2022

A Nomogram for Identifying HR+/Her2− Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy

por Yang, Hanzhao, Sun, Yadong, Wang, Peili, Qiao, Jianghua, Li, Lianfang, Lu, Zhenduo, Sun, Xianfu, Zhang, Chongjian, Chen, Xiuchun, Yan, Min, Cui, Shude, Wang, Chengzheng, Liu, Zhenzhen
Publicado 2023

Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen

por Zhu, Jiujun, Jiao, Dechuang, Wang, Chengzheng, Lu, Zhenduo, Chen, Xiuchun, Li, Lianfang, Sun, Xianfu, Qin, Li, Guo, Xuhui, Zhang, Chongjian, Qiao, Jianghua, Yan, Min, Cui, Shude, Liu, Zhenzhen
Publicado 2022

Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer

por Zhu, Jiujun, Jiao, Dechuang, Yan, Min, Chen, Xiuchun, Wang, Chengzheng, Lu, Zhenduo, Li, Lianfang, Sun, Xianfu, Qin, Li, Guo, Xuhui, Zhang, Chongjian, Qiao, Jianghua, Li, Jianbin, Fan, Zhimin, Wang, Haibo, Zhang, Jianguo, Yin, Yongmei, Fu, Peifen, Geng, Cuizhi, Jin, Feng, Jiang, Zefei, Cui, Shude, Liu, Zhenzhen
Publicado 2021